Market assessment of a "bioactive sol-gel-derived borate glass platform technology"

麦吉尔大学开发了一种基于溶胶-凝胶的平台技术，该技术正在申请专利，可生成具有独特化学和纹理特性的定制生物活性硼酸盐玻璃配方。迄今为止，这些独特的生物材料在骨和牙齿矿化以及伤口愈合方面的应用中表现出巨大的潜力。溶胶-凝胶工艺在低温下生产这些生物材料，提供可调的表面和形貌特征，从而增强细胞反应，并可能促进更快的组织再生。治疗性离子可容易地结合到玻璃结构中，然后可在降解时可控地释放。因此，该平台技术在硬组织和软组织再生的广泛应用中具有显著的潜力。为此，NSERC创新市场评估申请的目的是进行市场研究，以探索和验证生物活性硼酸盐玻璃技术平台最具吸引力的应用的需求和市场潜力，并确定这些极具前景的生物材料的最佳商业化策略。

McGill University has developed a patent-pending sol-gel based platform technology that generates bespoke, bioactive borate glass formulations with distinct chemical and textural properties. These unique biomaterials have so far demonstrated great potential in bone and teeth mineralization as well as in applications in wound healing. The sol-gel processing produces these biomaterials under low temperature, providing tunable surface and topographical features thus enhancing cellular responses and can potentially promote quicker tissue regeneration. Therapeutic ions can be easily incorporated into the glass structure, which can then be controllably released upon degradation. Therefore, this platform technology has significant potential in broad range applications for the regeneration of both hard and soft tissues. To this end, the purpose of this NSERC Idea to Innovation Market Assessment application is to undertake market research in order to explore and validate the needs and market potential of the most attractive applications for the bioactive borate glass technology platform, and to determine the optimum commercialization strategy for these highly promising biomaterials.